-
2000
Established TissueGene Asia Ltd. in Korea
-
2006
Changed the company name to Kolon Life Science, Inc.
-
2009
IPO (Korea, KOSDAQ)
-
2014
Constructed Bio Plant B1
-
2017
Started commercial manufacturing of cell and gene therapy products
-
2019
Completed Bio cGMP (planned) Plant B2
-
2020
Split off KOLON Life Science to KOLON Biotech